0001104659-21-150000.txt : 20211215
0001104659-21-150000.hdr.sgml : 20211215
20211215161849
ACCESSION NUMBER: 0001104659-21-150000
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211213
FILED AS OF DATE: 20211215
DATE AS OF CHANGE: 20211215
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kirschbaum Mark
CENTRAL INDEX KEY: 0001830211
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50626
FILM NUMBER: 211494413
MAIL ADDRESS:
STREET 1: 66 WEST 38TH STREET, APT. 19D
CITY: NEW YORK
STATE: NY
ZIP: 10018
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cyclacel Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001130166
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 911766850
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 CONNELL DRIVE
STREET 2: SUITE 1500
CITY: BERKELEY HEIGHTS
STATE: NJ
ZIP: 07922
BUSINESS PHONE: 908-517-7330
MAIL ADDRESS:
STREET 1: 200 CONNELL DRIVE
STREET 2: SUITE 1500
CITY: BERKELEY HEIGHTS
STATE: NJ
ZIP: 07922
FORMER COMPANY:
FORMER CONFORMED NAME: XCYTE THERAPIES INC
DATE OF NAME CHANGE: 20001218
4
1
tm2135363d1_4.xml
OWNERSHIP DOCUMENT
X0306
4
2021-12-13
0
0001130166
Cyclacel Pharmaceuticals, Inc.
CYCC
0001830211
Kirschbaum Mark
C/O CYCLACEL PHARMACEUTICALS, INC.,
200 CONNELL DRIVE, SUITE 1500
BERKELEY HEIGHTS
NJ
07922
0
1
0
0
Chief Medical Officer
Stock Option (right to buy)
3.45
2021-12-13
4
A
0
100000
0
A
2031-12-13
Common Stock
100000
100000
D
These securities are exercisable over a three-year period, with 1/36 of the options granted vesting on a monthly basis.
These securities were granted as part of the Issuer's annual compensation review to executive officers.
/s/ Mark Kirschbaum
2021-12-15